One could reasonably argue that Pendulums record of research backing and clinical trials (not to mention the ongoing series of the latter) provides peace of mind thats reflected in the price tags
glucagon-like peptide-1 receptor agonist treatments: a systematic review and network meta-analysis
The new program will apply to specific GLP-1s that are prescribed for weight loss: Foundayo (orforglipron) , a daily weight loss pill Wegovy (semaglutide) , in injection or pill form Zepbound (tirzepatide) , in the KwikPen multidose formulation
GLP-1s are integral in maintaining energy homeostasis and controlling glucose levels, particularly in individuals with T2D
Its also true that for most patients, the weight gain is only a symptom of other unhealthy nutrition and exercise choices
So I think that that is, thats really important for us, you know, in this space as well